Suppr超能文献

相似文献

1
Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.
J Biol Chem. 2007 Mar 30;282(13):9547-9555. doi: 10.1074/jbc.M610931200. Epub 2007 Feb 8.
3
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
J Pharmacol Exp Ther. 2005 Jun;313(3):1263-71. doi: 10.1124/jpet.105.083683. Epub 2005 Mar 10.
6
Gαi2- and Gαi3-specific regulation of voltage-dependent L-type calcium channels in cardiomyocytes.
PLoS One. 2011;6(9):e24979. doi: 10.1371/journal.pone.0024979. Epub 2011 Sep 26.
8
CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Eur J Immunol. 2003 Aug;33(8):2241-50. doi: 10.1002/eji.200323787.
9
Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
J Immunol. 2002 Jul 15;169(2):1037-49. doi: 10.4049/jimmunol.169.2.1037.

引用本文的文献

1
Protective effects of Gα deficiency in a murine heart-failure model of β-adrenoceptor overexpression.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2401-2420. doi: 10.1007/s00210-023-02751-8. Epub 2023 Oct 16.
2
A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model.
Nat Neurosci. 2023 Oct;26(10):1713-1725. doi: 10.1038/s41593-023-01432-2. Epub 2023 Sep 14.
4
Gαi protein subunit: A step toward understanding its non-canonical mechanisms.
Front Cell Dev Biol. 2022 Aug 24;10:941870. doi: 10.3389/fcell.2022.941870. eCollection 2022.
5
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.
Front Immunol. 2022 Jun 1;13:868579. doi: 10.3389/fimmu.2022.868579. eCollection 2022.
6
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.
Cancers (Basel). 2022 Jan 7;14(2):294. doi: 10.3390/cancers14020294.
8
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies.
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188628. doi: 10.1016/j.bbcan.2021.188628. Epub 2021 Sep 22.
9
Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases.
F1000Res. 2020 Oct 5;9:1197. doi: 10.12688/f1000research.26728.1. eCollection 2020.
10
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res. 2020 Nov 15;26(22):6051-6063. doi: 10.1158/1078-0432.CCR-20-1359. Epub 2020 Sep 1.

本文引用的文献

1
Chemokine receptor CXCR3: an unexpected enigma.
Curr Top Dev Biol. 2005;68:149-81. doi: 10.1016/S0070-2153(05)68006-4.
2
Impaired TGF-beta responses in peripheral T cells of G alpha i2-/- mice.
J Immunol. 2005 May 15;174(10):6122-8. doi: 10.4049/jimmunol.174.10.6122.
4
Accelerated transition from the double-positive to single-positive thymocytes in G alpha i2-deficient mice.
Int Immunol. 2005 Mar;17(3):233-43. doi: 10.1093/intimm/dxh204. Epub 2005 Jan 31.
5
G protein activation by G protein coupled receptors: ternary complex formation or catalyzed reaction?
Biochem Pharmacol. 2004 Sep 1;68(5):799-806. doi: 10.1016/j.bcp.2004.05.044.
6
Fatty acid-binding proteins--insights from genetic manipulations.
Prog Lipid Res. 2004 Jul;43(4):328-49. doi: 10.1016/j.plipres.2004.05.001.
8
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
J Biol Chem. 2004 Jul 16;279(29):30219-27. doi: 10.1074/jbc.M403595200. Epub 2004 May 17.
9
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Nature. 2004 Jan 22;427(6972):355-60. doi: 10.1038/nature02284.
10
Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA.
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):488-93. doi: 10.1073/pnas.0307549100. Epub 2003 Dec 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验